Abstract
Monoamine oxidases A and B (MAO A and B) are mammalian flavoenzymes bound to the outer mitochondrial membrane. They were discovered almost a century ago and they have been the subject of many biochemical, structural and pharmacological investigations due to their central role in neurotransmitter metabolism. Currently, the treatment of Parkinson’s disease involves the use of selective MAO B inhibitors such as rasagiline and safinamide. MAO inhibition was shown to exert a general neuroprotective effect as a result of the reduction of oxidative stress produced by these enzymes, which seems to be relevant also in non-neuronal contexts. MAOs were successfully expressed as recombinant proteins in Pichia pastoris, which allowed a thorough biochemical and structural characterization. These enzymes are characterized by a globular water-soluble main body that is anchored to the mitochondrial membrane through a C-terminal α-helix, similar to other bitopic membrane proteins. In both MAO A and MAO B the enzyme active site consists of a hydrophobic cavity lined by residues that are conserved in the two isozymes, except for few details that determine substrate and inhibitor specificity. In particular, human MAO B features a dual-cavity active site whose conformation depends on the size of the bound ligand. This article provides a comprehensive and historical review of MAOs and the state-of-the-art of these enzymes as membrane drug targets.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- EPR:
-
electron paramagnetic resonance
- GFP:
-
green fluorescence protein
- MAO:
-
monoamine oxidase
- MPTP:
-
1-metil 4-fenil 1,2,3,6-tetraidro-piridina
- ROS:
-
reactive oxygen species
References
Al-Nuaimi SK, Mackenzie EM, Baker GB (2012) Monoamine oxidase inhibitors and neuroprotection: a review. Am J Ther 19:436–448
Arolas JL, Broder C, Jefferson T, Guevara T, Sterchi EE, Bode W, Stöcker W, Becker-Pauly C, Gomis-Rüth FX (2012) Structural basis for the sheddase function of human meprin β metalloproteinase at the plasma membrane. Proc Natl Acad Sci U S A 109:16131–16136
Arslan B, Edmondson DE (2010) Expression of zebrafish (Danio rerio) monoamine oxidase (MAO) in Pichia pastoris: purification and comparison with human MAO A and MAO B. Prot Expr Purif 70:290–297
Bach AW, Lan NC, Johnson DL, Abell CW, Bembenek ME, Kwan SW, Seeburg PH, Shih JC (1988) cDNA cloning of human liver monoamine oxidase A and B: molecular differences in enzymatic properties. Proc Natl Acad Sci U S A 85:4934–4938
Binda C, Newton-Vinson P, Hubalek F, Edmondson DE, Mattevi A (2002) Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat Struct Biol 9:22–26
Binda C, Li M, Hubalek F, Restelli N, Edmondson DE, Mattevi A (2003) Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures. Proc Natl Acad Sci U S A 100:9750–9755
Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A (2007) Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem 50:5848–5852
Binda C, Valente S, Romanenghi M, Pilotto S, Cirilli R, Karytinos A, Ciossani G, Botrugno OA, Forneris F, Tardugno M, Edmondson DE, Minucci S, Mattevi A, Mai A (2010) Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2. J Am Chem Soc 132:6827–6833
Binda C, Aldeco M, Geldenhuys WJ, Tortorici M, Mattevi A, Edmondson DE (2011a) Molecular insights into human monoamine oxidase B inhibition by the glitazone anti-diabetes drugs. ACS Med Chem Lett 3:39–42
Binda C, Milczek EM, Bonivento D, Wang J, Mattevi A, Edmondson DE (2011b) Lights and shadows on monoamine oxidase inhibition in neuroprotective pharmacological therapies. Curr Top Med Chem 11:2788–2796
Bonivento D, Milczek EM, McDonald GR, Binda C, Holt A, Edmondson DE, Mattevi A (2010) Potentiation of ligand binding through cooperative effects in monoamine oxidase B. J Biol Chem 285:36849–36856
Chan SW, Dunlop RA, Rowe A, Double KL, Rodgers KJ (2012) L-DOPA is incorporated into brain proteins of patients treated for Parkinson’s disease, inducing toxicity in human neuroblastoma cells in vitro. Exp Neurol 238:29–37
Chen K, HF W, Shih JC (1996) Influence of C-terminus on monoamine oxidase A and B catalytic activity. J Neurochem 66:797–803
De Colibus L, Li M, Binda C, Lustig A, Edmondson DE, Mattevi A (2005) Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proc Natl Acad Sci U S A 102:12684–12689
Deeks ED (2015) Safinamide: first global approval. Drugs 75:705–711
Dézsi L, Vécsei L (2017) Monoamine oxidase B inhibitors in Parkinson’s disease. CNS Neurol Disord Drug Targets 16:425–439
Edmondson DE, Binda C, Wang J, Upadhyay AK, Mattevi A (2009) Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases. Biochemistry 48:4220–4230
Emmerstorfer A, Wriessnegger T, Hirz M, Pichler H (2014) Overexpression of membrane proteins from higher eukaryotes in yeasts. Appl Microbiol Biotechnol 98:7671–7698
Esteban G, Allan J, Samadi A, Mattevi A, Unzeta M, Marco-Contelles J, Binda C, Ramsay RR (2014) Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer’s disease. Biochim Biophys Acta 1844:1104–1110
Forneris F, Mattevi A (2008) Enzymes without borders: mobilizing substrates, delivering products. Science 321:213–216
Forneris F, Battaglioli E, Mattevi A, Binda C (2009) New roles of flavoproteins in molecular cell biology: histone demethylase LSD1 and chromatin. FEBS J 276:4304–4312
Fowler CJ, Mantle TJ, Tipton KF (1982) The nature of inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl, and pargyline. Biochem Pharmacol 17:3555–3561
Gottowik KJ, Malherbe P, Lang G, Da Prada M, Cesura AM (1995) Structure/function relationships of mitochondrial monoamine oxidase A and B chimeric forms. Eur J Biochem 230:934–942
Hare ML (1928) Tyramine oxidase: a new enzyme system in liver. Biochem J 22:968–979
Henderson Pozzi M, Fitzpatrick PF (2010) A lysine conserved in the monoamine oxidase family is involved in oxidation of the reduced flavin in mouse polyamine oxidase. Arch Biochem Biophys 498:83–88
Hroudová J, Singh N, Fišar Z, Ghosh KK (2016) Progress in drug development for Alzheimer’s disease: an overview in relation to mitochondrial energy metabolism. Eur J Med Chem 121:774–784
Huang CY, Shih HW, Lin LY, Tien YW, Cheng TJ, Cheng WC, Wong CH, Ma C (2012) Crystal structure of Staphylococcus aureus transglycosylase in complex with a lipid II analog and elucidation of peptidoglycan synthesis mechanism. Proc Natl Acad Sci U S A 109:6496–6501
Hubálek F, Binda C, Khalil A, Li M, Mattevi A, Castagnoli N, Edmondson DE (2005) Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors. J Biol Chem 280:15761–11576
Kaludercic N, Takimoto E, Nagayama T, Feng N, Lai EW, Bedja D, Chen K, Gabrielson KL, Blakely RD, Shih JC, Pacak K, Kass DA, Di Lisa F, Paolocci N (2010) Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ Res 106:193–202
Kearney EB, Salach JI, Walker WH, Seng RL, Zeszotek E, Singer TP (1971) The covalently-bound flavin of hepatic monoamine oxidase. Isolation and sequence of a flavin peptide and evidence for binding at the 8-alpha position. Eur J Biochem 24:321–327
Kim D, Baik SH, Kang S, Cho SW, Bae J, Cha MY, Sailor MJ, Mook-Jung I, Ahn KH (2016) Close correlation of monoamine oxidase activity with progress of Alzheimer’s disease in mice, observed by in vivo two-photon imaging. ACS Cent Sci 2:967–975
Knoll J (2000) (-)Deprenyl (Selegiline): past, present and future. Neurobiology (Bp) 8:179–199
Kumar MJ, Nicholls DG, Andersen JK (2003) Oxidative alpha-ketoglutarate dehydrogenase inhibition via subtle elevations in monoamine oxidase B levels results in loss of spare respiratory capacity – implications for Parkinson’s disease. J Biol Chem 278:46432–46439
Kurokawa S, Niwano S, Niwano H, Murakami M, Ishikawa S, Masaki Y, Tamaki H, Toda T, Noda Y, Shimizu T, Izumi T, Ako J (2014) Cardiomyocyte-derived mitochondrial superoxide causes myocardial electrical remodeling by downregulating potassium channels and related molecules. Circ J 78:1950–1959
Langston JW, Irwin I, Langston EB, Forno LS (1984a) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective for the Substantia nigra. Neurosci Lett 48:87–92
Langston JW, Irwin I, Langston EB, Forno LS (1984b) Pargyline prevents MPTP-induced parkinsonism in primates. Science 225:1480–1482
Li M, Hubálek F, Newton-Vinson P, Edmondson DE (2002) High-level expression of human liver monoamine oxidase A in Pichia pastoris: comparison with the enzyme expressed in Saccharomyes cerevisae. Prot Expr Purif 24:152–162
Li M, Binda C, Mattevi A, Edmondson DE (2006) Functional role of the “aromatic cage” in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins. Biochemistry 45:4775–4784
Ma J, Yoshimura M, Yamashita E, Nakagawa A, Ito A, Tsukihara T (2004) Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors. J Mol Biol 338:103–114
Mandel S, Weinreb O, Amit T, Youdim MB (2005) Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives. Brain Res Brain Res Rev 48:379–387
Maurel A, Hernandez C, Kunduzova O, Bompart G, Cambon C, Parini A, Frances B (2003) Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats. Am J Phys Heart Circ Phys 284:H1460–H1467
McNicholas S, Potterton E, Wilson KS, Noble ME (2011) Presenting your structures: the CCP4mg molecular-graphics software. Acta Crystallogr D Biol Crystallogr 67(Pt 4):386–394
Mialet-Perez J, D’Angelo R, Villeneuve C, Ordener C, Negre-Salvayre A, Parini A, Vindis C (2012) Serotonin 5-HT2A receptor-mediated hypertrophy is negatively regulated by caveolin-3 in cardiomyoblasts and neonatal cardiomyocytes. J Mol Cell Cardiol 52:502–510
Milczek E, Binda C, Rovida S, Mattevi A, Edmondson DE (2011) The “gating” residues Ile199 and Tyr326 in human monoamine oxidase B function in substrate and inhibitor recognition. FEBS J 278:4860–4869
Miller JR, Edmondson DE (1999) Influence of flavin analogue structure on the catalytic activities and flavinylation reactions of recombinant human liver monoamine oxidases A and B. J Biol Chem 274:23515–23525
Mitoma J, Ito A (1992) Mitochondrial targeting signal of rat liver monoamine oxidase B is located at its carboxy terminus. J Biochem 111:20–24
Monk BC, Tomasiak TM, Keniya MV, Huschmann FU, Tyndall JD, O’Connell JD 3rd, Cannon RD, McDonald JG, Rodriguez A, Finer-Moore JS, Stroud RM (2014) Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer. Proc Natl Acad Sci U S A 111:3865–3870
Nagy J, Salach JI (1981) Identity of the active site flavin-peptide fragments from the human “A”-form and the bovine “B”-form of monoamine oxidase. Arch Biochem Biophys 208:388–394
Nam SE, Kim AC, Paetzel M (2012) Crystal structure of Bacillus subtilis signal peptide peptidase A. J Mol Biol 419:347–358
Nandigama RK, Edmondson DE (2000) Influence of FAD structure on its binding and activity with the C406A mutant of recombinant human liver monoamine oxidase A. J Biol Chem 275:20527–20532
Newton-Vinson P, Hubálek F, Edmondson DE (2000) High-level expression of human liver monoamine oxidase B in Pichia pastoris. Prot Expr Purif 20:334–345
Orhan IE, Senol FS (2016) Designing multi-targeted therapeutics for the treatment of Alzheimer’s disease. Curr Top Med Chem 16:1889–1896
Ramsay RR, Majekova M, Medina M, Valoti M (2016) Key targets for multi-target ligands designed to combat neurodegeneration. Front Neurosci 10:375
Rebrin I, Geha RM, Chen K, Shih JC (2001) Effects of Carboxy-terminal truncations on the activity and solubility of human monoamine oxidase B. J Biol Chem 276:29499–29506
Robakis D, Fahn S (2015) Defining the role of the monoamine oxidase-B inhibitors for Parkinson’s disease. CNS Drugs 29:433–441
Russell SM, Davey J, Mayer RJ (1979) The vectorial orientation of human monoamine oxidase in the mitochondrial outer membrane. Biochem J 181:7–14
Salach JI (1979) Monoamine oxidase from beef liver mitochondria: simplified isolation procedure, properties, and determination of its cysteinyl flavin content. Arch Biochem Biophys 192:128–137
Schnaitman C, Erwin VG, Greenawalt JW (1967) Submitochondrial localization of monoamine oxidase – an enzymatic marker for outer membrane of rat liver mitochondria. J Cell Biol 32:719–735
Sivasubramaniam SD, Finch CC, Rodriguez MJ, Mahy N, Billett EE (2003) A comparative study of the expression of monoamine oxidase-A and -B mRNA and protein in non-CNS human tissues. Cell Tissue Res 313:291–300
Son SY, Ma J, Kondou Y, Yoshimura M, Yamashita E, Tsukihara T (2008) Structure of human monoamine oxidase A at 2.2 Å resolution: the control of opening the entry for substrates/inhibitors. Proc Natl Acad Sci U S A 105:5739–5744
Sung MT, Lai YT, Huang CY, Chou LY, Shih HW, Cheng WC, Wong CH, Ma C (2009) Crystal structure of the membrane-bound bifunctional transglycosylase PBP1b from Escherichia coli. Proc Natl Acad Sci U S A 106:8824–8829
Tang B, Zhao L, Liang R, Zhang Y, Wang L (2012) Magnetic nanoparticles: an improved method for mitochondrial isolation. Mol Med Rep 5:1271–1276
Tsirigos KD, Peters C, Shu N, Käll L, Elofsson A (2015) Nucleic Acids Research 43 (Webserver issue), W401–W407
Umbarkar P, Singh S, Arkat S, Bodhankar SL, Lohidasan S, Sitasawad SL (2015) Monoamine oxidase-a is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy. Free Radic Biol Med 87:263–273
Upadhyay AK, Edmondson DE (2008) Characterization of detergent purified recombinant rat liver monoamine oxidase B expressed in Pichia pastoris. Protein Expr Purif 59:349–356
Upadhyay AK, Edmondson DE (2009) Development of spin-labeled pargyline analogues as specific inhibitors of human monoamine oxidases A and B. Biochemistry 48:3928–3935
Upadhyay A, Borbat P, Wang J, Freed J, Edmondson DE (2008a) Determination of the oligomeric states of human and rat monoamine oxidases in the outer mitochondrial membrane and octyl β-D-glucopyranoside micelles using pulsed dipolar electron spin resonance spectroscopy. Biochemistry 47:1554–1566
Upadhyay AK, Wang J, Edmondson DE (2008b) Comparison of the structural properties of the active site cavities of human and rat monoamine oxidase A and B in their soluble and membrane-bound forms. Biochemistry 47:526–536
Urban P, Andersen JK, Hsu HPP, Pompon D (1991) Comparative membrane locations and activities of human monoamine oxidases expressed in yeast. FEBS Lett 286:142–146
Villeneuve C, Guilbeau-Frugier C, Sicard P, Lairez O, Ordener C, Duparc T, De Paulis D, Couderc B, Spreux-Varoquaux O, Tortosa F, Garnier A, Knauf C, Valet P, Borchi E, Nediani C, Gharib A, Ovize M, Delisle MB, Parini A, Mialet-Perez J (2013) p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice. Antioxid Redox Signal 18:5–18
Wang J, Edmondson DE (2010) High-level expression and purification of rat monoamine oxidase A (MAO A) in Pichia pastoris: comparison with human MAO A. Prot Expr Purif 70:211–217
Wang J, Edmondson DE (2011) Topological probes of monoamine oxidases A and B in rat liver mitochondria: inhibition by TEMPO-substituted pargyline analogues and inactivation by proteolysis. Biochemistry 50:2499–2505
Weyler W (1994) Functional expression of C-terminally truncated human monoamine oxidase type A in Saccharomyces cerevisiae. J Neural Transm 41:3–15
Weyler W, Salach JI (1985) Purification and properties of mitochondrial monoamine oxidase type A from human placenta. J Biol Chem 260:13199–13207
Weyler W, Titlow CC, Salach JI (1990) Catalytically active monoamine oxidase Type A from human liver expressed in Saccharomyces cerevisiae contains covalent FAD. Biochem Biophys Res Commun 173:1205–1211
Yeh JI, Chinte U, Du S (2008) Structure of glycerol-3-phosphate dehydrogenase, an essential monotopic membrane enzyme involved in respiration and metabolism. Proc Natl Acad Sci U S A 105:3280–3285
Zeller EA, Barsky J (1952) In vivo inhibition of liver and brain monoamine oxidase by 1-Isonicotinyl-2-isopropyl hydrazine. Proc Soc Exp Biol Med 81:459–461
Acknowledgements
This work was supported by Fondazione Cariplo (grant n. 2014-0672 to C.B.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Edmondson, D.E., Binda, C. (2018). Monoamine Oxidases. In: Harris, J., Boekema, E. (eds) Membrane Protein Complexes: Structure and Function. Subcellular Biochemistry, vol 87. Springer, Singapore. https://doi.org/10.1007/978-981-10-7757-9_5
Download citation
DOI: https://doi.org/10.1007/978-981-10-7757-9_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7756-2
Online ISBN: 978-981-10-7757-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)